Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195363 · ClinicalTrials.gov registry record · Phase 4
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT01195363 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 28 participants.
The verdict
NCT01195363, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.
Interventions
- DRUG quetiapine SR
- DRUG quetiapine sr placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195363
The ClinicalTrials.gov registry entry for NCT01195363 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quetiapine SR is the first listed.
NCT01195363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01195363 about?
NCT01195363 is a clinical study titled "Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder". To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.
What is the current status of trial NCT01195363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2007-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01195363?
The interventions under investigation include: quetiapine SR (DRUG), quetiapine sr placebo (DRUG).
Who is sponsoring clinical trial NCT01195363?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.